BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009;23:1008-1017. [PMID: 19470075 DOI: 10.1111/j.1468-3083.2009.03199.x] [Cited by in Crossref: 242] [Cited by in F6Publishing: 142] [Article Influence: 20.2] [Reference Citation Analysis]
Number Citing Articles
1 Wakabayashi M, Fujimoto N, Uenishi T, Danno K, Tanaka T. A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory bowel disease. Dermatology 2011;222:231-5. [PMID: 21540556 DOI: 10.1159/000324226] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
2 Saffie MG, Shroff A. A Case of Pyoderma Gangrenosum Misdiagnosed as Necrotizing Infection: A Potential Diagnostic Catastrophe. Case Rep Infect Dis 2018;2018:8907542. [PMID: 29854503 DOI: 10.1155/2018/8907542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Diotallevi F, Campanati A, Radi G, Brisigotti V, Molinelli E, Brancorsini D, Offidani A. Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature. Dermatol Ther 2019;32:e12928. [PMID: 30980454 DOI: 10.1111/dth.12928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Antiga E, Maglie R, Volpi W, Bianchi B, Berti E, Marzano AV, Caproni M. T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum. Clin Exp Immunol 2017;189:383-91. [PMID: 28518224 DOI: 10.1111/cei.12989] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
5 De Menezes D, Yusuf E, Borens O. Pyoderma Gangrenosum after Minor Trauma in a Pregnant Woman, Mistaken for Necrotizing Fasciitis: Report of a Case and Literature Review. Surgical Infections 2014;15:441-4. [DOI: 10.1089/sur.2012.110] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
6 Suárez-pérez J, Herrera-acosta E, López-navarro N, Vilchez-márquez F, Prieto J, Bosch R, Herrera E. Pioderma gangrenoso: Presentación de 15 casos y revisión de la literatura. Actas Dermo-Sifiliográficas 2012;103:120-6. [DOI: 10.1016/j.ad.2011.04.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
7 Campanati A, Brisigotti V, Ganzetti G, Molinelli E, Giuliodori K, Consales V, Racchini S, Bendia E, Offidani A. Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature. J Eur Acad Dermatol Venereol 2015;29:1245-7. [PMID: 25200926 DOI: 10.1111/jdv.12703] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
8 Deregnaucourt D, Buche S, Coopman S, Basraoui D, Turck D, Delaporte E. Pyoderma gangrenosum avec localisations pulmonaires traité par infliximab. Annales de Dermatologie et de Vénéréologie 2013;140:363-6. [DOI: 10.1016/j.annder.2013.01.428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
9 Kim D, Hur SM, Lee JS, Chin S, Lim CW, Kim Z. Pyoderma Gangrenosum Mimicking Wound Infection after Breast Cancer Surgery. J Breast Cancer 2021;24:409-16. [PMID: 34128363 DOI: 10.4048/jbc.2021.24.e25] [Reference Citation Analysis]
10 Meier B, Maul J, French LE. Pyoderma gangraenosum und Sweet-Syndrom: Hautmanifestationen autoinflammatorischer Erkrankungen. Hautarzt 2016;67:934-9. [DOI: 10.1007/s00105-016-3888-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mori T, Hiraiwa T, Ohtsuka M, Yamamoto T. Late-onset pyoderma gangrenosum following surgical operation in a patient with malignant melanoma. J Dermatol 2015;42:650-1. [PMID: 25858495 DOI: 10.1111/1346-8138.12850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Wu BC, Patel ED, Ortega-Loayza AG. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum. Br J Dermatol 2017;177:72-83. [PMID: 27864925 DOI: 10.1111/bjd.15193] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
13 Park JY, Lee J, Park JS, Jun JK. Successful vaginal birth after prior cesarean section in a patient with pyoderma gangrenosum. Obstet Gynecol Sci 2016;59:62-5. [PMID: 26866039 DOI: 10.5468/ogs.2016.59.1.62] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
14 Yuksel N, Ozdek S. Retinal vasculitis associated with pyoderma gangrenosum: a case report. J Ophthalmic Inflamm Infect 2012;2:239-41. [PMID: 22669709 DOI: 10.1007/s12348-012-0083-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Pereira N, Brites MM, Gonçalo M, Tellechea O, Figueiredo A. Pyoderma gangrenosum--a review of 24 cases observed over 10 years. Int J Dermatol 2013;52:938-45. [PMID: 23676016 DOI: 10.1111/j.1365-4632.2011.05451.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
16 Zolper EG, Harbour PW, Dekker PK, Schwitzer JA, Viramontes A, Evans KK. Post-Cesarean Section Pyoderma Gangrenosum Presenting with Vasopressor-dependent Shock: Long-term Follow-up after Delayed Primary Closure. Plast Reconstr Surg Glob Open 2021;9:e3427. [PMID: 33680673 DOI: 10.1097/GOX.0000000000003427] [Reference Citation Analysis]
17 Reese AM, Haag CK, Jung E, Nauta AC, Swerlick RA, Ortega-loayza AG. Pyoderma gangrenosum underrepresentation in non-dermatological literature. Diagnosis 2021;8:85-90. [DOI: 10.1515/dx-2019-0079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Koumaki D, Orfanoudaki E, Machaira A, Lagoudaki E, Krasagakis K, Koutroubakis IE. Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximab. Ann Gastroenterol 2020;33:433-5. [PMID: 32624666 DOI: 10.20524/aog.2020.0500] [Reference Citation Analysis]
19 Apalla Z, Lallas A, Karteridou A, Sotiriou E, Papaioannou K, Chaidemenos G. Pyoderma gangrenosum complicating mammaplasty. Int Wound J 2013;10:237-8. [PMID: 22222002 DOI: 10.1111/j.1742-481X.2011.00916.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
20 Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol. 2015;73:691-698. [PMID: 26253362 DOI: 10.1016/j.jaad.2015.06.021] [Cited by in Crossref: 116] [Cited by in F6Publishing: 68] [Article Influence: 19.3] [Reference Citation Analysis]
21 Kasper K, Manger B, Junger A, Reichert B, Sievers R, Herdtle S. [Pyoderma gangrenosum following AICD implantation: differential diagnosis to necrotizing fasciitis]. Anaesthesist 2012;61:47-51. [PMID: 22249404 DOI: 10.1007/s00101-011-1949-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Jockenhöfer F, Herberger K, Schaller J, Hohaus KC, Stoffels-Weindorf M, Ghazal PA, Augustin M, Dissemond J. Trizentrische Analyse von Kofaktoren und Komorbidität des Pyoderma gangraenosum. J Dtsch Dermatol Ges 2016;14:1023-31. [PMID: 27767262 DOI: 10.1111/ddg.12791_g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Ene N, Bélénotti P, Benyamine A, Sovaila S, Ben Sahla Talet MH, Kaminsky P, Serratrice J, Weiller PJ. [Granulomatosis with polyangiitis (previously Wegener's granulomatosis) mimicking malingering]. Rev Med Interne 2014;35:540-2. [PMID: 23886885 DOI: 10.1016/j.revmed.2013.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Tsutsumi Y, Odani K, Kaneko Y, Hashizume H, Tachibana M. Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression. Case Rep Pathol 2021;2021:8819560. [PMID: 33564484 DOI: 10.1155/2021/8819560] [Reference Citation Analysis]
25 Barańska-rybak W, Kakol M, Naesstrom M, Komorowska O, Sokolowska-wojdyło M, Roszkiewicz J. A Retrospective Study of 12 Cases of Pyoderma Gangrenosum: Why We Should Avoid Surgical Intervention and What Therapy to Apply. The American Surgeon 2011;77:1644-9. [DOI: 10.1177/000313481107701236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
26 Tomioka T, Soma K, Sato Y, Miura K, Endo A. Pyoderma gangrenosum on the nose. Auris Nasus Larynx 2018;45:1130-4. [PMID: 29753583 DOI: 10.1016/j.anl.2018.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
27 Adışen E, Erduran F, Gürer MA. Pyoderma Gangrenosum: A Report of 27 Patients. Int J Low Extrem Wounds 2016;15:148-54. [PMID: 27009790 DOI: 10.1177/1534734616639172] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
28 Na HD, Yan H, Park CH. Misdiagnosis of Pyoderma Gangrenosum Increases Medical Costs and Prolongs Hospital Stay: A Case Report. Int J Low Extrem Wounds 2021;:15347346211011870. [PMID: 33891524 DOI: 10.1177/15347346211011870] [Reference Citation Analysis]
29 Deckers IE, van der Zee HH, Prens EP. Epidemiology of Hidradenitis Suppurativa: Prevalence, Pathogenesis, and Factors Associated with the Development of HS. Curr Derm Rep 2014;3:54-60. [DOI: 10.1007/s13671-013-0064-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
30 Cafardi J, Sami N. Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: report of a case and review of the literature. Case Rep Dermatol 2014;6:239-44. [PMID: 25493078 DOI: 10.1159/000368824] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
31 Tanaka K, Araki T, Okita Y, Fujikawa H, Kawamura M, Uchida K, Mohri Y, Kusunoki M. Pyoderma gangrenosum occurring at the peri-ileal pouch-anal anastomosis in a patient with ulcerative colitis: report of a case. Surg Today 2014;44:783-5. [DOI: 10.1007/s00595-012-0463-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
32 Romańska-Gocka K, Cieścińska C, Zegarska B, Schwartz RA, Cieściński J, Olszewska-Słonina D, Czajkowski R. Pyoderma gangrenosum with monoclonal IgA gammopathy and pulmonary tuberculosis. Illustrative case and review. Postepy Dermatol Alergol 2015;32:137-41. [PMID: 26015785 DOI: 10.5114/pdia.2014.40974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
33 Rodríguez-Zúñiga MJM, Heath MS, Gontijo JRV, Ortega-Loayza AG. Pyoderma gangrenosum: a review with special emphasis on Latin America literature. An Bras Dermatol 2019;94:729-43. [PMID: 31789268 DOI: 10.1016/j.abd.2019.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
34 Seo HI, Lee HJ, Han KH. Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis. Intest Res 2018;16:155-7. [PMID: 29422812 DOI: 10.5217/ir.2018.16.1.155] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
35 Tunçez Akyürek F, Akyurek M, Zekey E, Can I, Saylam Kurtipek G. Pyoderma gangrenosum with thymoma and myasthenia gravis: A case report. J Cosmet Dermatol 2021;20:943-6. [PMID: 32920928 DOI: 10.1111/jocd.13717] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Tomasini C, Michelerio A. Erosive pustular dermatosis of the scalp: A neutrophilic folliculitis within the spectrum of neutrophilic dermatoses: A clinicopathologic study of 30 cases. J Am Acad Dermatol 2019;81:527-33. [PMID: 30617027 DOI: 10.1016/j.jaad.2018.10.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
37 Ogata K, Takamori H, Ikuta Y, Tanaka H, Ozaki N, Hayashi H, Ogawa K, Doi K. Pyoderma gangrenosum in an abdominal surgical site: a case report. Surg Case Rep 2015;1:122. [PMID: 26943446 DOI: 10.1186/s40792-015-0124-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
38 Hoff NP, Bölke E, Matuschek C, Peiper M, Neumann NJ, Gerber PA. Pyoderma gangrenosum. Wien Klin Wochenschr 2010;122:75. [PMID: 20213372 DOI: 10.1007/s00508-010-1310-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66:409-415. [PMID: 21745697 DOI: 10.1016/j.jaad.2010.12.025] [Cited by in Crossref: 202] [Cited by in F6Publishing: 135] [Article Influence: 20.2] [Reference Citation Analysis]
40 Bhat RM. Pyoderma gangrenosum: An update. Indian Dermatol Online J 2012;3:7-13. [PMID: 23130252 DOI: 10.4103/2229-5178.93482] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
41 González-Moreno J, Ruíz-Ruigomez M, Callejas Rubio JL, Ríos Fernández R, Ortego Centeno N. Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature. Lupus 2015;24:130-7. [PMID: 25199808 DOI: 10.1177/0961203314550227] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
42 Güth U, Wagner S, Huang DJ, Hess TH. Pyoderma gangrenosum of the vaginal vault after vaginal hysterectomy: only the correct diagnosis of a rare entity can prevent long-term morbidity. Arch Gynecol Obstet 2013;288:79-82. [DOI: 10.1007/s00404-012-2692-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Franco S, Foresta G, Pulvirenti E, Giannone G. Ulcerative colitis complicated by atypical peristomal pyoderma gangrenosum: . Inflammatory Bowel Diseases 2011;17:E111-2. [DOI: 10.1002/ibd.21784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
44 Vallini V, Andreini R, Bonadio A. Pyoderma Gangrenosum: A Current Problem as Much as an Unknown One. The International Journal of Lower Extremity Wounds 2017;16:191-201. [DOI: 10.1177/1534734617710980] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
45 Sehgal VN, Pandhi D, Khurana A. Nonspecific genital ulcers. Clinics in Dermatology 2014;32:259-74. [DOI: 10.1016/j.clindermatol.2013.08.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
46 Patel DK, Locke M, Jarrett P. Pyoderma gangrenosum with pathergy: A potentially significant complication following breast reconstruction. J Plast Reconstr Aesthet Surg 2017;70:884-92. [PMID: 28476284 DOI: 10.1016/j.bjps.2017.03.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
47 Pourmorteza M, Tawadros F, Bader G, Al-Tarawneh M, Cook E, Shams W, Young M. Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis C. Am J Case Rep 2016;17:434-8. [PMID: 27345376 DOI: 10.12659/ajcr.898611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
48 Billings SD. Common and critical inflammatory dermatoses every pathologist should know. Mod Pathol 2020;33:107-17. [PMID: 31676787 DOI: 10.1038/s41379-019-0400-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Koshelev MV, Garrison PA, Wright TS. Concurrent Hidradenitis Suppurativa, Inflammatory Acne, Dissecting Cellulitis of the Scalp, and Pyoderma Gangrenosum in a 16-Year-Old Boy. Pediatr Dermatol 2014;31:e20-1. [DOI: 10.1111/pde.12196] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
50 Soleimani T, Sasor SE, Spera L, Eppley BE, Socas J, Chu MW, Tholpady SS. Pediatric pyoderma gangrenosum: is it just big wounds on little adults? Journal of Surgical Research 2016;206:113-7. [DOI: 10.1016/j.jss.2016.06.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
51 Bhaskaran B, Mathew MJ, Vijayan KN, Zacharia A. Pyoderma gangrenosum: A clinician's nightmare. J Family Med Prim Care 2016;5:698-700. [PMID: 28217611 DOI: 10.4103/2249-4863.197300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
52 Ratnagobal S, Sinha S. Pyoderma gangrenosum: guideline for wound practitioners. Journal of Wound Care 2013;22:68-72. [DOI: 10.12968/jowc.2013.22.2.68] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
53 Almukhtar R, Armenta AM, Martin J, Goodwin BP, Vincent B, Lee B, Dacso MM. Delayed diagnosis of post-surgical pyoderma gangrenosum: A multicenter case series and review of literature. Int J Surg Case Rep 2018;44:152-6. [PMID: 29501933 DOI: 10.1016/j.ijscr.2018.02.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
54 Argüelles-Arias F, Castro-Laria L, Lobatón T, Aguas-Peris M, Rojas-Feria M, Barreiro-de Acosta M, Soto-Escribano P, Calvo-Moya M, Ginard-Vicens D, Chaparro-Sánchez M. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci. 2013;58:2949-2954. [PMID: 23828140 DOI: 10.1007/s10620-013-2762-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
55 Shen J, Zhang W, Jiang X. Pyoderma gangrenosum after cesarean section treated with skin graft: A case report. Medicine (Baltimore) 2019;98:e15380. [PMID: 31045786 DOI: 10.1097/MD.0000000000015380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
56 Ashchyan HJ, Nelson CA, Stephen S, James WD, Micheletti RG, Rosenbach M. Neutrophilic dermatoses: Pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses. J Am Acad Dermatol 2018;79:1009-22. [PMID: 29653213 DOI: 10.1016/j.jaad.2017.11.063] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 10.3] [Reference Citation Analysis]
57 Thomas KS, Batchelor JM, Bath-hextall F, Chalmers JR, Clarke T, Crowe S, Delamere FM, Eleftheriadou V, Evans N, Firkins L, Greenlaw N, Lansbury L, Lawton S, Layfield C, Leonardi-bee J, Mason J, Mitchell E, Nankervis H, Norrie J, Nunn A, Ormerod AD, Patel R, Perkins W, Ravenscroft JC, Schmitt J, Simpson E, Whitton ME, Williams HC. A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease. Programme Grants Appl Res 2016;4:1-488. [DOI: 10.3310/pgfar04180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Nakajima N, Ikeuchi M, Izumi M, Kuriyama M, Nakajima H, Tani T. Successful treatment of wound breakdown caused by pyoderma gangrenosum after total knee arthroplasty. The Knee 2011;18:453-5. [DOI: 10.1016/j.knee.2010.06.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
59 Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takahashi Y, Takesue Y, Matsumoto T, Tomita N. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease. Digestion. 2012;85:295-301. [PMID: 22584791 DOI: 10.1159/000336719] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
60 Inoue S, Furuta JI, Fujisawa Y, Onizawa S, Ito S, Sakiyama M, Kobayashi K, Kanou T, Iijima S, Ohi T, Okubo C, Moriyama Y, Okiyama N, Fujimoto M. Pyoderma gangrenosum and underlying diseases in Japanese patients: A regional long-term study. J Dermatol 2017;44:1281-4. [PMID: 28635156 DOI: 10.1111/1346-8138.13937] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
61 Lu JD, Milakovic M, Ortega-Loayza AG, Marzano AV, Alavi A. Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1. Expert Opin Investig Drugs 2020;29:1179-85. [PMID: 32880206 DOI: 10.1080/13543784.2020.1819981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
62 Poiraud C, Gagey-caron V, Barbarot S, Durant C, Ayari S, Stalder J. Pyoderma gangrenosum cutanéomuqueux et systémique. Annales de Dermatologie et de Vénéréologie 2010;137:212-5. [DOI: 10.1016/j.annder.2010.01.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
63 Cinotti E, Labeille B, Perrot JL, Pallot-Prades B, Cambazard F. Certolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritis. Clin Exp Dermatol 2014;39:750-1. [PMID: 24984791 DOI: 10.1111/ced.12393] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
64 Gade M, Studstrup F, Andersen AK, Hilberg O, Fogh C, Bendstrup E. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature. Respir Med 2015;109:443-50. [PMID: 25622759 DOI: 10.1016/j.rmed.2014.12.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
65 Eisendle K, Thuile T, Deluca J, Pichler M. Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases. Adv Wound Care (New Rochelle) 2020;9:405-25. [PMID: 32320362 DOI: 10.1089/wound.2020.1160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
66 Solovan C, Smiszek R, Wickenhauser C, Chiticariu E. Postoperative pyoderma gangrenosum in association with renal cell carcinoma and chronic lymphocytic leukemia. Infect Dis Ther 2013;2:75-80. [PMID: 25135825 DOI: 10.1007/s40121-013-0008-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
67 Shah M, Sachdeva M, Gefri A, Jfri A. Paraneoplastic pyoderma gangrenosum in solid organ malignancy: a literature review. Int J Dermatol 2019;59:154-8. [DOI: 10.1111/ijd.14637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
68 Laughter MR, Florek AG, Wisell J, Newman S. Dermatitis Artefacta, a Form of Factitial Disorder Imposed on Self, Misdiagnosed as Pyoderma Gangrenosum for Eight Years. Cureus 2020;12:e9054. [PMID: 32782873 DOI: 10.7759/cureus.9054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Gupta AS, Ortega-Loayza AG. Ocular pyoderma gangrenosum: A systematic review. J Am Acad Dermatol 2017;76:512-8. [PMID: 27836332 DOI: 10.1016/j.jaad.2016.08.049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
70 Dillingham CS, Jorizzo J. Managing Ulcers Associated with Pyoderma Gangrenosum with a Urinary Bladder Matrix and Negative-Pressure Wound Therapy. Adv Skin Wound Care 2019;32:70-6. [DOI: 10.1097/01.asw.0000546120.32681.bc] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
71 Chuamanochan M, Weller K, Feist E, Kallinich T, Maurer M, Kümmerle-Deschner J, Krause K. State of care for patients with systemic autoinflammatory diseases - Results of a tertiary care survey. World Allergy Organ J 2019;12:100019. [PMID: 30937142 DOI: 10.1016/j.waojou.2019.100019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
72 Yamasaki K, Yamanaka K, Zhao Y, Iwano S, Takei K, Suzuki K, Yamamoto T. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study. J Dermatol 2020;47:1383-90. [PMID: 32804433 DOI: 10.1111/1346-8138.15533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
73 Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, Ortega-Loayza AG, Cohen J, McCalmont TH, Demer AM, Mansh MD, Hylwa SA, Liu J, Shinkai K. Clinical Features of Neutrophilic Dermatosis Variants Resembling Necrotizing Fasciitis. JAMA Dermatol 2019;155:79-84. [PMID: 30383110 DOI: 10.1001/jamadermatol.2018.3890] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
74 Jockenhöfer F, Herberger K, Schaller J, Hohaus KC, Stoffels-Weindorf M, Ghazal PA, Augustin M, Dissemond J. Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum. J Dtsch Dermatol Ges 2016;14:1023-30. [PMID: 27767288 DOI: 10.1111/ddg.12791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
75 van Donkelaar CE, de Haan JMH, Lange JFM, de Vries M, Horváth B. Pseudo-wound infection after a caesarean section: Case report of unrecognized Pyoderma Gangrenosum. Int J Surg Case Rep 2020;69:79-82. [PMID: 32305662 DOI: 10.1016/j.ijscr.2020.03.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Altunay I, Kucukunal A, Sarikaya S, Tukenmez Demirci G. A favourable response to surgical intervention and hyperbaric oxygen therapy in pyoderma gangrenosum. Int Wound J 2014;11:350-3. [PMID: 23106966 DOI: 10.1111/j.1742-481X.2012.01102.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
77 Clarke K, Chintanaboina J. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease. Clin Rev Allergy Immunol 2019;57:179-93. [PMID: 29754190 DOI: 10.1007/s12016-018-8690-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
78 Tolkachjov SN, Fahy AS, Cerci FB, Wetter DA, Cha SS, Camilleri MJ. Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases. Mayo Clin Proc 2016;91:1267-79. [PMID: 27489052 DOI: 10.1016/j.mayocp.2016.05.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 5.6] [Reference Citation Analysis]
79 Dantas SG, Quintella LP, Fernandes NC. Exuberant pyoderma gangrenosum in a patient with autoimmune hepatitis. An Bras Dermatol 2017;92:114-7. [PMID: 28225969 DOI: 10.1590/abd1806-4841.20174871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
80 Starnes TW, Bennin DA, Bing X, Eickhoff JC, Grahf DC, Bellak JM, Seroogy CM, Ferguson PJ, Huttenlocher A. The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood. 2014;123:2703-2714. [PMID: 24421327 DOI: 10.1182/blood-2013-07-516948] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
81 Soutou B, Vignon-Pennamen D, Chosidow O. [Neutrophilic dermatoses]. Rev Med Interne 2011;32:306-13. [PMID: 20933309 DOI: 10.1016/j.revmed.2010.08.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
82 White M, Adams L, Phan C, Erdag G, Totten M, Lee R, Lu X, Mehta S, Miller LS, Zhang SX. Disseminated sporotrichosis following iatrogenic immunosuppression for suspected pyoderma gangrenosum. Lancet Infect Dis 2019;19:e385-91. [PMID: 31473127 DOI: 10.1016/S1473-3099(19)30421-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
83 Haag CK, Nutan F, Cyrus JW, Satpathy J, Shinkai K, Ortega Loayza AG. Pyoderma gangrenosum misdiagnosis resulting in amputation: A review. J Trauma Acute Care Surg 2019;86:307-13. [DOI: 10.1097/ta.0000000000002096] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
84 Choi HY, Nickless D, Tee W, Tong E, Aboltins CA. Acute scrotal ulcers in typhoid Fever: case report and literature review. Trop Med Health 2015;43:69-73. [PMID: 25859155 DOI: 10.2149/tmh.2014-28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Haag C, Hansen T, Hajar T, Latour E, Keller J, Shinkai K, Ortega-Loayza AG. Comparison of Three Diagnostic Frameworks for Pyoderma Gangrenosum. J Invest Dermatol 2021;141:59-63. [PMID: 32445742 DOI: 10.1016/j.jid.2020.04.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
86 Lockwood S, Li D, Butler D, Tsiaras W, Joyce C, Mostaghimi A. The validity of the diagnostic code for pyoderma gangrenosum in an electronic database. Br J Dermatol 2018;179:216-7. [DOI: 10.1111/bjd.16446] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
87 Vaidy K, Winderman R, Rabinowitz SS, Schwarz SM. Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease. JPGN Reports 2020;1:e008. [DOI: 10.1097/pg9.0000000000000008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Galimberti RL, Vacas AS, Bollea Garlatti ML, Torre AC. The role of interleukin-1β in pyoderma gangrenosum. JAAD Case Rep 2016;2:366-8. [PMID: 27709123 DOI: 10.1016/j.jdcr.2016.07.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
89 Li J, Kelly R. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent. Journal of the American Academy of Dermatology 2013;69:565-9. [DOI: 10.1016/j.jaad.2013.05.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
90 Wu XR, Mukewar S, Kiran RP, Remzi FH, Hammel J, Shen B. Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease. J Crohns Colitis 2013;7:e171-7. [PMID: 22959399 DOI: 10.1016/j.crohns.2012.08.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
91 Leventhal JS, Tlougan BE, Mandell JA, Friedman-kien AE, Meehan SA. Postoperative pathergic pyoderma gangrenosum after aortic aneurysm repair: Correspondence. Int J Dermatol 2013;52:1401-3. [DOI: 10.1111/j.1365-4632.2011.05198.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 Be M, Cha HJ, Park C, Park Y, Jung H, Lee Y, Jegal Y. Multiple pulmonary cavitary nodules with pyoderma gangrenosum in patient with rheumatoid arthritis. Ann Transl Med 2016;4:39. [PMID: 26889492 DOI: 10.3978/j.issn.2305-5839.2016.01.07] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Allen CP, Hull J, Wilkison N, Burge SM. Pediatric pyoderma gangrenosum with splenic and pulmonary involvement. Pediatr Dermatol 2013;30:497-9. [PMID: 23627664 DOI: 10.1111/pde.12138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
94 Thampy RS, Al-niaimi F, Lyon C, Duff CG, Leatherbarrow B. Management of Cicatricial Ectropion Secondary to Pyoderma Gangrenosum. Orbit 2013;33:129-31. [DOI: 10.3109/01676830.2013.851250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Sharma P, Dhungel S. All that is red is not cellulitis. European Journal of Internal Medicine 2014;25:e17-8. [DOI: 10.1016/j.ejim.2013.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Wollina U, Haroske G. Pyoderma gangraenosum. Current Opinion in Rheumatology 2011;23:50-6. [DOI: 10.1097/bor.0b013e328341152f] [Cited by in Crossref: 57] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
97 Bruzzese V. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy. J Clin Rheumatol. 2012;18:413-415. [PMID: 23188209 DOI: 10.1097/rhu.0b013e318278b84c] [Cited by in Crossref: 42] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
98 Afifi L, Sanchez IM, Wallace MM, Braswell SF, Ortega-loayza AG, Shinkai K. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review. Journal of the American Academy of Dermatology 2018;78:1195-1204.e1. [DOI: 10.1016/j.jaad.2017.12.049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
99 Kirchner A, Kulkarni V, Rajkumar J, Usman A, Hassan S, Lee EY. Readability assessment of patient-facing online educational content for pyoderma gangrenosum. J Am Acad Dermatol 2021:S0190-9622(21)00822-7. [PMID: 33882279 DOI: 10.1016/j.jaad.2021.04.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Vernaci GM, Meroni M, Dieci MV, Saibene T, Montesco MC, Orvieto E, Cattelan A, Ghiotto C, Miglietta F, Guarneri V, Cagol M. Postsurgical Pyoderma Gangrenosum in a Breast Cancer Patient: A Case Report and Literature Review. Case Rep Oncol 2021;14:160-4. [PMID: 33776698 DOI: 10.1159/000509745] [Reference Citation Analysis]
101 Chen W, Xiang L, Li L. Therapeutic Efficacy of the Combination Therapy of Corticosteroids and 5-Aminosalicylic Acid for Treatment of Pyoderma Gangrenosum with Ulcerative Colitis. Indian J Dermatol 2020;65:38-41. [PMID: 32029938 DOI: 10.4103/ijd.IJD_505_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Gameiro A, Pereira N, Cardoso JC, Gonçalo M. Pyoderma gangrenosum: challenges and solutions. Clin Cosmet Investig Dermatol 2015;8:285-93. [PMID: 26060412 DOI: 10.2147/CCID.S61202] [Cited by in Crossref: 49] [Cited by in F6Publishing: 13] [Article Influence: 8.2] [Reference Citation Analysis]
103 Ebrad S, Severyns M, Benzakour A, Roze B, Derancourt C, Odri GA, Rouvillain JL. Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature. Int Orthop 2018;42:239-45. [PMID: 29119297 DOI: 10.1007/s00264-017-3672-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
104 Hrin ML, Bashyam AM, Huang WW, Feldman SR. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review. Int J Dermatol 2021. [PMID: 33739458 DOI: 10.1111/ijd.15539] [Reference Citation Analysis]
105 Besner Morin C, Côté B, Belisle A. An interesting case of pyoderma gangrenosum with immature hystiocytoid neutrophils. J Cutan Pathol 2018;45:63-6. [DOI: 10.1111/cup.13053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
106 Schlick K, Regauer S, Beham-schmid C, Cerroni L, Rohn A, Deutsch AJ, Linkesch W, Neumeister P, Aigelsreiter A. Pyoderma Gangrenosum Heralding Acute Leukemia for Months: Diagnostic Hint Written on the Skin. JCO 2011;29:e506-8. [DOI: 10.1200/jco.2010.34.3855] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
107 Marzano AV, Borghi A, Wallach D, Cugno M. A Comprehensive Review of Neutrophilic Diseases. Clinic Rev Allerg Immunol 2018;54:114-30. [DOI: 10.1007/s12016-017-8621-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 15.8] [Reference Citation Analysis]
108 Partridge ACR, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials. Br J Dermatol 2018;179:290-5. [PMID: 29478243 DOI: 10.1111/bjd.16485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
109 Lőrincz M, Kleszky M, Szalóki Jr. T, Szalóki T. Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis. Orvosi Hetilap 2010;151:144-7. [DOI: 10.1556/oh.2010.28786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
110 Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol. 2010;162:100-107. [PMID: 20636397 DOI: 10.1111/j.1365-2249.2010.04201.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
111 Sasor SE, Soleimani T, Chu MW, Cook JA, Nicksic PJ, Tholpady SS. Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases. J Wound Care 2018;27:S4-8. [PMID: 29334018 DOI: 10.12968/jowc.2018.27.Sup1.S4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
112 Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13:191-211. [PMID: 22356259 DOI: 10.2165/11595240-000000000-00000] [Cited by in Crossref: 209] [Cited by in F6Publishing: 121] [Article Influence: 23.2] [Reference Citation Analysis]
113 Andrade P, Brites MM, Figueiredo A. Synchronous pyoderma gangrenosum and inflammatory bowel disease, healing after total proctocolectomy. An Bras Dermatol 2012;87:637-9. [PMID: 22892784 DOI: 10.1590/s0365-05962012000400022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
114 Sakiyama M, Kobayashi T, Nagata Y, Fujimoto N, Satoh T, Tajima S. Bullous pyoderma gangrenosum: a case report and review of the published work. J Dermatol 2012;39:1010-5. [PMID: 22974277 DOI: 10.1111/j.1346-8138.2012.01676.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
115 McPhie ML, Fletcher J, Machado MO, Carvalho AF, Piguet V, Alavi A. A Systematic Review of Depression and Anxiety in Adults with Pyoderma Gangrenosum. Adv Skin Wound Care 2021;34:432-6. [PMID: 34260421 DOI: 10.1097/01.ASW.0000755920.76330.21] [Reference Citation Analysis]
116 Shiba-Tokuchi K, Moriuchi R, Morita Y, Takahashi H, Obara N, Okazaki M, Shimizu S. Ulceration on an old cervical operative scar: Post-surgical pyoderma gangrenosum induced by recent mastectomy. J Dermatol 2017;44:e244-5. [PMID: 28557085 DOI: 10.1111/1346-8138.13929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Jaimes-López N, Molina V, Arroyave JE, Vasquez LA, Ruiz AC, Castaño R, Ruiz MH. Development of pyoderma gangrenosum during therapy with infliximab. J Dermatol Case Rep 2009;3:20-3. [PMID: 21886723 DOI: 10.3315/jdcr.2009.1027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
118 Wu XR, Shen B. Diagnosis and management of parastomal pyoderma gangrenosum. Gastroenterol Rep (Oxf) 2013;1:1-8. [PMID: 24759661 DOI: 10.1093/gastro/got013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
119 Kolios A, Maul J, Meier B, Kerl K, Traidl‐hoffmann C, Hertl M, Zillikens D, Röcken M, Ring J, Facchiano A, Mondino C, Yawalkar N, Contassot E, Navarini A, French L. Canakinumab in adults with steroid‐refractory pyoderma gangrenosum. Br J Dermatol 2015;173:1216-23. [DOI: 10.1111/bjd.14037] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
120 Cabalag MS, Wasiak J, Lim SW, Raiola FB. Inpatient Management of Pyoderma Gangrenosum: Treatments, Outcomes, and Clinical Implications. Annals of Plastic Surgery 2015;74:354-60. [DOI: 10.1097/sap.0b013e31829565f3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 4.2] [Reference Citation Analysis]
121 Freitas VMP, Pereira SM, Enokihara MMSES, Cestari SDCP. Pyoderma gangrenosum associated with left iliac vein compression syndrome: presentation of difficult diagnosis. An Bras Dermatol 2017;92:129-31. [PMID: 29267470 DOI: 10.1590/abd1806-4841.20176109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
122 Hanafusa T, Azukizawa H, Umegaki N, Tani M, Yamaguchi Y, Katayama I. Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease. J Dermatol. 2011;38:507-510. [PMID: 21352279 DOI: 10.1111/j.1346-8138.2010.01009.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
123 Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20:213-227. [PMID: 24105394 DOI: 10.1097/01.mib.0000436959.62286.f9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 16] [Article Influence: 9.7] [Reference Citation Analysis]
124 Wang J, Prenner J, Wang W, Sakuraba A, Hyman N, Dalal S, Hurst R, Cohen RD, Umanskiy K, Shogan BD, Alpert L, Rubin DT, Colwell J, Pekow J. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2020;51:1365-72. [PMID: 32383278 DOI: 10.1111/apt.15766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
125 Calonje E, Brenn T, Lazar A. Neutrophilic and eosinophilic dermatoses. McKee's Pathology of the Skin. Elsevier; 2012. pp. 631-57. [DOI: 10.1016/b978-1-4160-5649-2.00015-9] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
126 Yamamoto T. Pyoderma gangrenosum: An important dermatologic condition occasionally associated with rheumatic diseases. WJR 2015;5:101. [DOI: 10.5499/wjr.v5.i2.101] [Cited by in CrossRef: 3] [Article Influence: 0.5] [Reference Citation Analysis]
127 Reid AB, Stanley P, Grinsell D, Daffy JR. Severe, Steroid-responsive, Myositis Mimicking Necrotizing Fasciitis following Orthopedic Surgery: A Pyoderma Variant with Myonecrosis. Plast Reconstr Surg Glob Open 2014;2:e175. [PMID: 25289368 DOI: 10.1097/GOX.0000000000000124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
128 Hackl S, Merkel P, Hungerer S, Friederichs J, Müller N, Militz M, Bühren V. [Pyoderma gangrenosum after intramedullary nailing of tibial shaft fracture: A differential diagnosis to necrotizing fasciitis]. Unfallchirurg 2015;118:1062-6. [PMID: 25672810 DOI: 10.1007/s00113-015-2737-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
129 Vacas AS, Torre AC, Bollea-garlatti ML, Warley F, Galimberti RL. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients. Int J Dermatol 2017;56:386-91. [DOI: 10.1111/ijd.13591] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
130 Nelson CA, Stephen S, Ashchyan HJ, James WD, Micheletti RG, Rosenbach M. Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. J Am Acad Dermatol 2018;79:987-1006. [PMID: 29653210 DOI: 10.1016/j.jaad.2017.11.064] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
131 Quist SR, Kraas L. Treatment options for pyoderma gangrenosum. J Dtsch Dermatol Ges 2017;15:34-40. [PMID: 28140549 DOI: 10.1111/ddg.13173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
132 Speeckaert R, De Smet L, De Schepper S, van Geel N, Veramme J, Vanderdonckt L, Temmerman L, Lambert J, Beele H. Pyoderma gangrenosum with granuloma formation: not always a benign disorder. J Eur Acad Dermatol Venereol 2016;30:188-9. [PMID: 25174437 DOI: 10.1111/jdv.12699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
133 Cunha VS, Magno V, Wendt LRR, Furian TQ, Passos EP. Pyoderma Gangrenosum Postlaparoscopy: A Rare Complication. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2012;22:e45-7. [DOI: 10.1097/sle.0b013e318241c120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Tay DZ, Tan KW, Tay YK. Pyoderma gangrenosum: a commonly overlooked ulcerative condition. J Family Med Prim Care 2014;3:374-8. [PMID: 25657946 DOI: 10.4103/2249-4863.148113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
135 Leiphart PA, Lam CC, Foulke GT. Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement. JAAD Case Rep 2018;4:98-100. [PMID: 29379860 DOI: 10.1016/j.jdcr.2017.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
136 Kotzampassakis N, Ksontini R. Pyoderma gangrenosum after inguinal hernia repair. Hernia. 2012;16:345-347. [PMID: 21086145 DOI: 10.1007/s10029-010-0752-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
137 Ordi-ros J, Cosiglio FJ. Indicaciones terapéuticas actuales de la talidomida y la lenalidomida. Medicina Clínica 2014;142:360-4. [DOI: 10.1016/j.medcli.2013.04.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
138 Alhumam A. Rare Case of Pyoderma Gangrenosum in the Setting of PAPA Syndrome in a 12-Year-Old Child. Int J Low Extrem Wounds 2021;:15347346211036023. [PMID: 34382449 DOI: 10.1177/15347346211036023] [Reference Citation Analysis]
139 Hammond JB, Pflibsen LR, Kruger EA, Casey WJ 3rd, Noland SS, Lettieri SC, Rebecca AM, Struve SL, Teven CM. Pyoderma gangrenosum confined to the irradiated chest wall of the reconstructed breast. Clin Case Rep 2021;9:445-9. [PMID: 33489195 DOI: 10.1002/ccr3.3553] [Reference Citation Analysis]
140 Gupta AS, Greiling TM, Ortega-Loayza AG. A systematic review of pyoderma gangrenosum with pulmonary involvement: clinical presentation, diagnosis and management. J Eur Acad Dermatol Venereol 2018;32:e295-7. [PMID: 29377399 DOI: 10.1111/jdv.14828] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
141 Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45:202-210. [PMID: 23334898 DOI: 10.1007/s12016-012-8351-x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 62] [Article Influence: 13.7] [Reference Citation Analysis]
142 Haimes H, Corey K, Mostaghimi A, Schmidt B, Gellis SE, Liang MG. Pediatric facial pyoderma gangrenosum preceding the diagnosis of inflammatory bowel disease. Pediatr Dermatol 2020;37:764-6. [PMID: 32342563 DOI: 10.1111/pde.14186] [Reference Citation Analysis]